Episode Details
Back to EpisodesBiogen Enters GA Treatment Market After Major Acquisition
Published 2 months ago
Description
Pharma giant Biogen announces its intention to acquire Apellis in a multi-billion dollar deal; a recently approved first-of-its-kind presbyopia drop is commercially launched; and Kodiak Sciences releases phase 3 data for its diabetic retinopathy drug candidate.
Learn more about your ad choices. Visit megaphone.fm/adchoices